Trial Profile
Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 12 May 2020
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 08 May 2020 Status changed from recruiting to completed.
- 23 Jul 2019 Planned primary completion date changed from 30 May 2019 to 30 Jul 2019.
- 11 Mar 2019 Planned End Date changed from 1 Jan 2019 to 30 July 2019.